Polymyositis
📧 Sign up to get email alerts when something new happens for Polymyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Environmental Risk Factors for Myositis in Military Personnel
A completed NIEHS-sponsored clinical study evaluated environmental risk factors for myositis in military personnel, including dermatomyositi…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Adult and Juvenile Myositis
This entry reports that a NIEHS-sponsored clinical trial investigating adult and juvenile myositis is currently recruiting for dermatomyosit…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] [Phase 3]
Pfizer is conducting a Phase 3 trial of PF-06823859 to study its effects in people with active idiopathic inflammatory myopathies, specifica…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy [Phase 3]
A Phase 3 trial evaluating the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) [Phase 3]
A Phase 3 trial to evaluate the efficacy and safety of subcutaneous anifrolumab added to standard of care versus placebo with standard of ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Environmental Risk Factors for the Anti-synthetase Syndrome
This NIEHS-sponsored clinical trial investigates environmental risk factors for anti-synthetase syndrome, enrolling patients with inflammato…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies [Phase 3]
This is a Phase 3 clinical trial investigating how the study drug Dazukibart works in people with Dermatomyositis and Polymyositis, with rec…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
The sponsor reports an ongoing Phase 2/3 trial assessing the safety and efficacy of ULSC in reducing disease severity and aiding steroid tap…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Add-on Intravenous Immunoglobulins in Early Myositis [Phase 2, Phase 3]
A Phase 2/Phase 3 add-on intravenous immunoglobulin study for early inflammatory myopathies (myositis) is active but not currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
This Clinical Trial Update notes that studies on the natural history and pathogenesis of autoimmune and connective tissue diseases have comp…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Rheumatology Patient Registry and Biorepository
This Clinical Trial Update describes a Yale University-led rheumatology patient registry and biorepository that is currently recruiting to c…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
The MIHRA PRISMS clinical study for myositis is currently recruiting, sponsored by the Myositis International Health & Research Collaborativ…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease [Phase 1, Phase 2]
Miltenyi Biomedicine is conducting Phase 1/2 trials of CAR-T cell therapy targeting B cells for autoimmune diseases, including systemic lupu…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis [Phase 2]
A Phase 2 clinical trial is planned to evaluate the efficacy and safety of PN-101, an allogeneic mitochondrial therapy, in patients with ref…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases [Phase 1, Phase 2]
Clinical trial update for anti-CD19 CAR T-cell therapy being explored in refractory systemic autoimmune diseases, including systemic lupus e…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial updates describe infusion of mesenchymal stem cells in multiple autoimmune diseases and indicate the …
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis [Phase 1]
Amgen's Phase 1 study evaluating VIB7734 in multiple autoimmune diseases including systemic lupus erythematosus, cutaneous lupus erythematos…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Rheumatology Diet Study
A rheumatology dietary intervention study sponsored by the University of Central Florida is currently recruiting, listing multiple autoimmun…
-
CLINICAL_TRIALS research · 2016-08-26Clinical Trial Update: Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy
Completed observational study estimating the prevalence of polymyositis and dermatomyositis in the Normandy region.
-
CLINICAL_TRIALS research · 2015-11-06Clinical Trial Update: Dermatomyositis and Polymyositis Registry
A clinical trial registry entry for Dermatomyositis and Polymyositis sponsored by Phoenix Neurological Associates; the current status is unk…
-
CLINICAL_TRIALS research · 2008-03-05Clinical Trial Update: Genetic and Family Studies of Inherited Muscle Diseases
NIAMS-sponsored clinical trial investigating genetic and familial factors in inherited muscle diseases has completed, involving conditions s…